2016.jpegAs we ramp for a great 2017 we are looking back on what we did in 2016. As we ramp for a great 2017 we are looking back on what we did in 2016. In that spirit, here are the top 5 blog posts of 2016 by views.

FDA Introduces a New Test Concept: “Complementary Diagnostics”

FDA-Approved Biomarker Panels: The Good, The Bad, and The Ugly

Biomarkers and Commercial Strategy: Comparing The Three Leading Breast Cancer Panels

10 Diagnostics Innovators: Smaller Companies Are Leading the Way

Introducing the Personalized Medicine Scorecard™: Drug Companies Edition

Real-Time COVID R&D Tracking

As COVID-19 infections continue to spread, organizations with technologies or devices that can support new drug, vaccine, or test development have a life-saving contribution to make. The Amplion Intelligence Platform can alert you to new COVID-19 trial activities in real-time and automatically match you to partners who need your unique capabilities immediately. It’s already tomorrow somewhere, so let us help you start today.  Learn More

Request Access